# Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

> **NCT04068155** · NA · RECRUITING · sponsor: **Alpha Tau Medical LTD.** · enrollment: 80 (estimated)

## Conditions studied

- Skin Cancer
- Cutaneous Tumor
- Cutaneous Metastasis

## Interventions

- **DEVICE:** DaRT- Diffusing Alpha-emitters Radiation Therapy

## Key facts

- **NCT ID:** NCT04068155
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04068155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04068155, "Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04068155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
